Company profile for Midatech Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Midatech is fully focussed on enhancing and extending the lives of patients with rare and serious cancers. We have built an organization distinguished by world-class scientists with a talent for developing and applying our novel drug delivery technologies to improve existing, or develop new, treatments for these diseases. Our driving philosophy is to seize scientific and clinical opportunities and invest in programmes and par...
Midatech is fully focussed on enhancing and extending the lives of patients with rare and serious cancers. We have built an organization distinguished by world-class scientists with a talent for developing and applying our novel drug delivery technologies to improve existing, or develop new, treatments for these diseases. Our driving philosophy is to seize scientific and clinical opportunities and invest in programmes and partnerships to get these treatments to approval and commercialisation. Midatech Pharma is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Oddfellows House 19 Newport Road Cardiff CF24 0AA
Telephone
Telephone
+44 (0)1235 888300
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Midatech plots pivot beyond delivery tech with Bioasis buyout
Midatech plots pivot beyond delivery tech with Bioasis buyout

20 Dec 2022

// Nick Paul Taylor FIERCEPHARMA

https://www.fiercepharma.com/pharma/teetering-edge-midatech-plots-pivot-beyond-drug-delivery-platform-bioasis-buyout

Nick Paul Taylor FIERCEPHARMA
20 Dec 2022

https://www.globenewswire.com/news-release/2022/12/13/2573101/0/en/Bioasis-Technologies-Inc-Announces-Merger-with-Midatech-Pharma-plc.html

GLOBENEWSWIRE
13 Dec 2022

https://www.accesswire.com/731666/Midatech-Pharma-PLC-Announces-Proposed-Acquisition-of-Bioasis-Technologies-Inc

ACCESSWIRE
13 Dec 2022

https://www.nasdaq.com/press-release/midatech-pharma-plc-announces-interim-results-for-the-six-months-to-30-june-2022-2022

NASDAQ
14 Sep 2022

https://www.accesswire.com/705853/Midatech-Pharma-PLC-Announces-MTX110-Development-for-the-Treatment-of-Glioma

ACCESSWIRE
21 Jun 2022

https://www.accesswire.com/697474/Midatech-Pharma-PLC-Announces-Receipt-of-NASDAQ-Notice

ACCESSWIRE
14 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty